keyword
https://read.qxmd.com/read/36479472/dietary-supplements-for-obesity
#21
REVIEW
Gabriele Bonetti, Karen L Herbst, Kevin Donato, Kristjana Dhuli, Aysha Karim Kiani, Barbara Aquilanti, Valeria Velluti, Giuseppina Matera, Amerigo Iaconelli, Matteo Bertelli
Obesity and associated complications including diabetes, cardiometabolic dysfunction, disability, malignancy and premature mortality are considered epidemic. Research on obesity is therefore of worldwide importance. The development of obesity is a multifactorial phenomenon with contributions from biological, behavioral, genetic and environmental factors. Obesity and its associated issues require various lifestyle modifications and treatment options such medication, exercise, diet, surgery, pharmacological therapy and dietary supplements...
June 2022: Journal of Preventive Medicine and Hygiene
https://read.qxmd.com/read/36424487/functional-analysis-of-structural-variants-in-single-cells-using-strand-seq
#22
JOURNAL ARTICLE
Hyobin Jeong, Karen Grimes, Kerstin K Rauwolf, Peter-Martin Bruch, Tobias Rausch, Patrick Hasenfeld, Eva Benito, Tobias Roider, Radhakrishnan Sabarinathan, David Porubsky, Sophie A Herbst, Büşra Erarslan-Uysal, Johann-Christoph Jann, Tobias Marschall, Daniel Nowak, Jean-Pierre Bourquin, Andreas E Kulozik, Sascha Dietrich, Beat Bornhauser, Ashley D Sanders, Jan O Korbel
Somatic structural variants (SVs) are widespread in cancer, but their impact on disease evolution is understudied due to a lack of methods to directly characterize their functional consequences. We present a computational method, scNOVA, which uses Strand-seq to perform haplotype-aware integration of SV discovery and molecular phenotyping in single cells by using nucleosome occupancy to infer gene expression as a readout. Application to leukemias and cell lines identifies local effects of copy-balanced rearrangements on gene deregulation, and consequences of SVs on aberrant signaling pathways in subclones...
November 24, 2022: Nature Biotechnology
https://read.qxmd.com/read/36385154/genome-wide-association-study-of-a-lipedema-phenotype-among-women-in-the-uk-biobank-identifies-multiple-genetic-risk-factors
#23
JOURNAL ARTICLE
Yann C Klimentidis, Zhao Chen, Manuel L Gonzalez-Garay, Dionysios Grigoriadis, Ege Sackey, Alan Pittman, Pia Ostergaard, Karen L Herbst
Lipedema is a common disorder characterized by excessive deposition of subcutaneous adipose tissue (SAT) in the legs, hips, and buttocks, mainly occurring in adult women. Although it appears to be heritable, no specific genes have yet been identified. To identify potential genetic risk factors for lipedema, we used bioelectrical impedance analysis and anthropometric data from the UK Biobank to identify women with and without a lipedema phenotype. Specifically, we identified women with both a high percentage of fat in the lower limbs and a relatively small waist, adjusting for hip circumference...
November 16, 2022: European Journal of Human Genetics: EJHG
https://read.qxmd.com/read/36142221/indications-of-peripheral-pain-dermal-hypersensitivity-and-neurogenic-inflammation-in-patients-with-lipedema
#24
JOURNAL ARTICLE
Adri Chakraborty, Rachelle Crescenzi, Timaj A Usman, Andrea J Reyna, Maria E Garza, Sara Al-Ghadban, Karen L Herbst, Paula M C Donahue, Joseph M Rutkowski
Lipedema is a disease with abnormally increased adipose tissue deposition and distribution. Pain sensations have been described in the clinical evaluation of lipedema, but its etiology remains poorly understood. We hypothesized that pain sensitivity measurements and ex vivo quantitation of neuronal cell body distribution in the skin would be lipedema stage-dependent, and could, thus, serve to objectively characterize neuropathic pain in lipedema. The pain was assessed by questionnaire and peripheral cutaneous mechanical sensitization (von-Frey) in lipedema ( n = 27) and control ( n = 23) consenting female volunteers...
September 7, 2022: International Journal of Molecular Sciences
https://read.qxmd.com/read/36005333/new-canadian-and-provincial-records-of-coleoptera-resulting-from-annual-canadian-food-inspection-agency-surveillance-for-detection-of-non-native-potentially-invasive-forest-insects
#25
JOURNAL ARTICLE
Graham S Thurston, Alison Slater, Inna Nei, Josie Roberts, Karen McLachlan Hamilton, Jon D Sweeney, Troy Kimoto
The arrival and establishment of adventive, invasive forest insects are a threat to the health, diversity, and productivity of forests in Canada and the world at large, and their early detection is essential for successful eradication and management. For that reason, the Canadian Food Inspection Agency (CFIA) conducts annual surveys at high risk sites such as international ports and freight terminals, industrial zones, and disposal sites for solid wood packaging material using two methods: (1) semiochemical-baited traps deployed in a total of about 63-80 sites per year in British Columbia (BC), Ontario (ON), Quebec (QC), New Brunswick (NB), Nova Scotia (NS), and Newfoundland and Labrador (NL); and (2) rearing of insects from bolts collected from stressed trees and incubated in modified shipping containers in four cities (Vancouver, Toronto, Montreal, and Halifax)...
August 6, 2022: Insects
https://read.qxmd.com/read/35811389/a-case-series-of-lymphatic-injuries-after-suction-lipectomy-in-women-with-lipedema
#26
JOURNAL ARTICLE
Thomas F Wright, Karen L Herbst
BACKGROUND Lipedema is a loose connective tissue disease characterized by disproportionate subcutaneous adipose tissue hypertrophy in the extremities. There is evidence of impaired lymphatic function in women with lipedema at all stages without signs of trophic skin changes associated with hereditary or acquired lymphedema. A modification of suction lipectomy is used to treat lipedema tissue and can reduce pain, limb size, and limb swelling and reduce the need for compression in women with lipedema. Studies have shown that modified liposuction can improve quality of life and mobility...
July 11, 2022: American Journal of Case Reports
https://read.qxmd.com/read/35730758/initiation-of-antipsychotic-treatment-for-amphetamine-induced-psychosis-and-its-impact-on-length-of-stay
#27
JOURNAL ARTICLE
Claire Herbst, Megan O'Connell, Brittany L Melton, Karen E Moeller
INTRODUCTION: A risk of amphetamine use is amphetamine-induced psychosis (AIP). Symptoms of AIP include hallucinations, delusions, and agitation. While AIP may resolve with abstinence from amphetamines, antipsychotics are commonly used despite not being FDA approved. The primary objective of this study was to compare length of stay (LOS) for patients with AIP treated with antipsychotics vs untreated. Secondary aims were to determine antipsychotic prescribed, proportion of patients utilizing as needed doses, time to initiation, and readmissions...
June 22, 2022: Journal of Pharmacy Practice
https://read.qxmd.com/read/35713632/circulating-tumor-dna-kinetics-predict-progression-free-and-overall-survival-in-egfr-tki-treated-patients-with-egfr-mutant-nsclc-swog-s1403
#28
JOURNAL ARTICLE
Philip C Mack, Jieling Miao, Mary W Redman, James Moon, Sarah B Goldberg, Roy S Herbst, Mary Ann Melnick, Zenta Walther, Fred R Hirsch, Katerina Politi, Karen Kelly, David R Gandara
PURPOSE: Dynamic changes in circulating tumor DNA (ctDNA) are under investigation as an early indicator of treatment outcome. EXPERIMENTAL DESIGN: Serial plasma ctDNA (baseline, 8 weeks, and at progression) was prospectively incorporated into the SWOG S1403 clinical trial of afatinib ± cetuximab in tyrosine kinase inhibitor-naïve, EGFR mutation tissue-positive non-small cell lung cancer. RESULTS: EGFR mutations were detected in baseline ctDNA in 77% (82/106) of patients, associated with the presence of brain and/or liver metastases and M1B stage...
September 1, 2022: Clinical Cancer Research
https://read.qxmd.com/read/35707862/lymphatic-function-and-anatomy-in-early-stages-of-lipedema
#29
JOURNAL ARTICLE
John C Rasmussen, Melissa B Aldrich, Caroline E Fife, Karen L Herbst, Eva M Sevick-Muraca
OBJECTIVE: Lipedema is an inflammatory subcutaneous adipose tissue disease that develops in women and may progress to lipolymphedema, a condition similar to lymphedema, in which lymphatic dysfunction results in irresolvable edema. Because it has been shown that dilated lymphatic vessels, impaired pumping, and dermal backflow are associated with presymptomatic, cancer-acquired lymphedema, this study sought to understand whether these abnormal lymphatic characteristics also characterize early stages of lipedema prior to lipolymphedema development...
July 2022: Obesity
https://read.qxmd.com/read/35658002/phase-ii-randomized-study-of-ramucirumab-and-pembrolizumab-versus-standard-of-care-in-advanced-non-small-cell-lung-cancer-previously-treated-with-immunotherapy-lung-map-s1800a
#30
JOURNAL ARTICLE
Karen L Reckamp, Mary W Redman, Konstantin H Dragnev, Katherine Minichiello, Liza C Villaruz, Bryan Faller, Tareq Al Baghdadi, Susan Hines, Leah Everhart, Louise Highleyman, Vassiliki Papadimitrakopoulou, David R Gandara, Karen Kelly, Roy S Herbst
PURPOSE: Resistance to immune checkpoint inhibition (ICI) in advanced non-small-cell lung cancer (NSCLC) represents a major unmet need. Combining ICI with vascular endothelial growth factor (VEGF)/VEGF receptor inhibition has yielded promising results in multiple tumor types. METHODS: In this randomized phase II Lung-MAP nonmatch substudy (S1800A), patients ineligible for a biomarker-matched substudy with NSCLC previously treated with ICI and platinum-based chemotherapy and progressive disease at least 84 days after initiation of ICI were randomly assigned to receive ramucirumab plus pembrolizumab (RP) or investigator's choice standard of care (SOC: docetaxel/ramucirumab, docetaxel, gemcitabine, and pemetrexed)...
June 3, 2022: Journal of Clinical Oncology
https://read.qxmd.com/read/35657120/subcutaneous-adipose-tissue-edema-in-lipedema-revealed-by-noninvasive-3t-mr-lymphangiography
#31
JOURNAL ARTICLE
Rachelle Crescenzi, Paula M C Donahue, Maria Garza, Niral J Patel, Chelsea Lee, Kelsey Guerreso, Greg Hall, Yu Luo, Sheau-Chiann Chen, Karen L Herbst, Michael Pridmore, Aaron W Aday, Joshua A Beckman, Manus J Donahue
BACKGROUND: Lipedema exhibits excessive lower-extremity subcutaneous adipose tissue (SAT) deposition, which is frequently misidentified as obesity until lymphedema presents. MR lymphangiography may have relevance to distinguish lipedema from obesity or lymphedema. HYPOTHESIS: Hyperintensity profiles on 3T MR lymphangiography can identify distinct features consistent with SAT edema in participants with lipedema. STUDY TYPE: Prospective cross-sectional study...
June 3, 2022: Journal of Magnetic Resonance Imaging: JMRI
https://read.qxmd.com/read/34928864/reflections-on-new-evidence-on-crisis-standards-of-care-in-the-covid-19-pandemic
#32
JOURNAL ARTICLE
Benjamin Tolchin, Stephen R Latham, Lori Bruce, Lauren E Ferrante, Katherine Kraschel, Karen Jubanyik, Sarah C Hull, Jennifer L Herbst, Jennifer Kapo, Ernest D Moritz, John Hughes, Mark D Siegel, Mark R Mercurio
Crisis standards of care have been widely developed by healthcare systems and states in the United States during the COVID-19 pandemic, and in some rare cases have actually been used to allocate medical resources. All publicly available U.S. crisis standards of care with a mechanism for allocating scarce resources make use of the Sequential Organ Failure Assessment (SOFA) score in hopes of assigning scarce resources to those patients who are more likely to survive. We reflect on the growing body of evidence suggesting that the SOFA score has limited accuracy in predicting mortality among patients hospitalized with COVID-19 and that the SOFA score systematically disfavors Black patients...
2021: Journal of Clinical Ethics
https://read.qxmd.com/read/34753703/egfr-high-copy-number-together-with-high-egfr-protein-expression-predicts-improved-outcome-for-cetuximab-based-therapy-in-squamous-cell-lung-cancer-analysis-from-swog-s0819-a-phase-iii-trial-of-chemotherapy-with-or-without-cetuximab-in-advanced-nsclc
#33
JOURNAL ARTICLE
Fred R Hirsch, Mary W Redman, James Moon, Francesco Agustoni, Roy S Herbst, Thomas J Semrad, Marileila Varella-Garcia, Chris J Rivard, Karen Kelly, David R Gandara, Philip C Mack
BACKGROUND: The phase III S0819 trial investigated addition of cetuximab to first-line chemotherapy (CT) in NSCLC. Subgroup analyses suggested an OS benefit among patients with EGFR copy number gain in squamous cell carcinomas (SCC), (HR = 0.58 [0.39-0.86], P = .0071). A more detailed model based on EGFR FISH, EGFR IHC and KRAS mutation status was evaluated to yield a more precise predictive paradigm of cetuximab-based therapy in advanced NSCLC. METHODS: FISH was performed using the Colorado Scoring Criteria; H-Score was used to quantify EGFR IHC expression (cut-off ≥ 200)...
January 2022: Clinical Lung Cancer
https://read.qxmd.com/read/34655982/tau-in-the-brain-interstitial-fluid-is-fragmented-and-seeding-competent
#34
JOURNAL ARTICLE
Erica Barini, Gudrun Plotzky, Yulia Mordashova, Jonas Hoppe, Esther Rodriguez-Correa, Sonja Julier, Florie LePrieult, Ina Mairhofer, Mario Mezler, Sandra Biesinger, Miroslav Cik, Marcus W Meinhardt, Ebru Ercan-Herbst, Dagmar E Ehrnhoefer, Andreas Striebinger, Karen Bodie, Corinna Klein, Laura Gasparini, Kerstin Schlegel
In Alzheimer disease, Tau pathology is thought to propagate from cell to cell throughout interconnected brain areas. However, the forms of Tau released into the brain interstitial fluid (ISF) in vivo during the development of Tauopathy and their pathological relevance remain unclear. Combining in vivo microdialysis and biochemical analysis, we find that in Tau transgenic mice, human Tau (hTau) present in brain ISF is truncated and comprises at least 10 distinct fragments spanning the entire Tau protein. The fragmentation pattern is similar across different Tau transgenic models, pathological stages and brain areas...
September 17, 2021: Neurobiology of Aging
https://read.qxmd.com/read/34535009/racial-disparities-in-the-sofa-score-among-patients-hospitalized-with-covid-19
#35
JOURNAL ARTICLE
Benjamin Tolchin, Carol Oladele, Deron Galusha, Nitu Kashyap, Mary Showstark, Jennifer Bonito, Michelle C Salazar, Jennifer L Herbst, Steve Martino, Nancy Kim, Katherine A Nash, Max Jordan Nguemeni Tiako, Shireen Roy, Rebeca Vergara Greeno, Karen Jubanyik
BACKGROUND: Sequential Organ Failure Assessment (SOFA) score predicts probability of in-hospital mortality. Many crisis standards of care suggest the use of SOFA scores to allocate medical resources during the COVID-19 pandemic. RESEARCH QUESTION: Are SOFA scores elevated among Non-Hispanic Black and Hispanic patients hospitalized with COVID-19, compared to Non-Hispanic White patients? STUDY DESIGN AND METHODS: Retrospective cohort study conducted in Yale New Haven Health System, including 5 hospitals with total of 2681 beds...
2021: PloS One
https://read.qxmd.com/read/34529684/the-potential-impact-of-triage-protocols-on-racial-disparities-in-clinical-outcomes-among-covid-positive-patients-in-a-large-academic-healthcare-system
#36
JOURNAL ARTICLE
Shireen Roy, Mary Showstark, Benjamin Tolchin, Nitu Kashyap, Jennifer Bonito, Michelle C Salazar, Jennifer L Herbst, Katherine A Nash, Max Jordan Nguemeni Tiako, Karen Jubanyik, Nancy Kim, Deron Galusha, Karen H Wang, Carol Oladele
BACKGROUND: The COVID-19 pandemic has had a devastating impact in the United States, particularly for Black populations, and has heavily burdened the healthcare system. Hospitals have created protocols to allocate limited resources, but there is concern that these protocols will exacerbate disparities. The sequential organ failure assessment (SOFA) score is a tool often used in triage protocols. In these protocols, patients with higher SOFA scores are denied resources based on the assumption that they have worse clinical outcomes...
2021: PloS One
https://read.qxmd.com/read/34429332/phase-ii-study-of-durvalumab-plus-tremelimumab-as-therapy-for-patients-with-previously-treated-anti-pd-1-pd-l1-resistant-stage-iv-squamous-cell-lung-cancer-lung-map-substudy-s1400f-nct03373760
#37
MULTICENTER STUDY
Natasha B Leighl, Mary W Redman, Naiyer Rizvi, Fred R Hirsch, Philip C Mack, Lawrence H Schwartz, James L Wade, William J Irvin, Sreekanth C Reddy, Jeffrey Crawford, Jeffrey D Bradley, Thomas E Stinchcombe, Suresh S Ramalingam, Jieling Miao, Katherine Minichiello, Roy S Herbst, Vassiliki A Papadimitrakopoulou, Karen Kelly, David R Gandara
INTRODUCTION: S1400F is a non-match substudy of Lung Cancer Master Protocol (Lung-MAP) evaluating the immunotherapy combination of durvalumab and tremelimumab to overcome resistance to anti-programmed death ligand 1 (PD-(L)1) therapy in patients with advanced squamous lung carcinoma (sq non-small-cell lung cancer (NSCLC)). METHODS: Patients with previously treated sqNSCLC with disease progression after anti-PD-(L)1 monotherapy, who did not qualify for any active molecularly targeted Lung-MAP substudies, were eligible...
August 2021: Journal for Immunotherapy of Cancer
https://read.qxmd.com/read/34264316/nivolumab-plus-ipilimumab-vs-nivolumab-for-previously-treated-patients-with-stage-iv-squamous-cell-lung-cancer-the-lung-map-s1400i-phase-3-randomized-clinical-trial
#38
RANDOMIZED CONTROLLED TRIAL
Scott N Gettinger, Mary W Redman, Lyudmila Bazhenova, Fred R Hirsch, Philip C Mack, Lawrence H Schwartz, Jeffrey D Bradley, Thomas E Stinchcombe, Natasha B Leighl, Suresh S Ramalingam, Susan S Tavernier, Hui Yu, Joseph M Unger, Katherine Minichiello, Louise Highleyman, Vassiliki A Papadimitrakopoulou, Karen Kelly, David R Gandara, Roy S Herbst
IMPORTANCE: Nivolumab plus ipilimumab is superior to platinum-based chemotherapy in treatment-naive advanced non-small cell lung cancer (NSCLC). Nivolumab is superior to docetaxel in advanced pretreated NSCLC. OBJECTIVE: To determine whether the addition of ipilimumab to nivolumab improves survival in patients with advanced, pretreated, immunotherapy-naive squamous (Sq) NSCLC. DESIGN, SETTING, AND PARTICIPANTS: The Lung Cancer Master Protocol (Lung-MAP) S1400I phase 3, open-label randomized clinical trial was conducted from December 18, 2015, to April 23, 2018, randomizing patients in a 1:1 ratio to nivolumab alone or combined with ipilimumab...
September 1, 2021: JAMA Oncology
https://read.qxmd.com/read/34121088/a-young-woman-with-excessive-fat-in-lower-extremities-develops-disordered-eating-and-is-subsequently-diagnosed-with-anorexia-nervosa-lipedema-and-hypermobile-ehlers-danlos-syndrome
#39
JOURNAL ARTICLE
Thomas F Wright, Karen L Herbst
BACKGROUND Lipedema is a loose connective tissue disease that causes disproportionate subcutaneous fat accumulation on the extremities. As a result of the increased subcutaneous tissue accumulation, lipedema is often confused with obesity by both physicians and patients. Poor awareness and limited diagnosis of lipedema contribute to the confusion of lipedema with obesity and can lead to decreased body image acceptance. Patients with lipedema may have anorexia nervosa, an eating disorder characterized by a distortion of body image, incorrect self-identification of being overweight, restricted eating behavior, and a relentless pursuit of weight loss...
June 14, 2021: American Journal of Case Reports
https://read.qxmd.com/read/34049453/standard-of-care-for-lipedema-in-the-united-states
#40
JOURNAL ARTICLE
Karen L Herbst, Linda Anne Kahn, Emily Iker, Chuck Ehrlich, Thomas Wright, Lindy McHutchison, Jaime Schwartz, Molly Sleigh, Paula Mc Donahue, Kathleen H Lisson, Tami Faris, Janis Miller, Erik Lontok, Michael S Schwartz, Steven M Dean, John R Bartholomew, Polly Armour, Margarita Correa-Perez, Nicholas Pennings, Edely L Wallace, Ethan Larson
BACKGROUND: Lipedema is a loose connective tissue disease predominantly in women identified by increased nodular and fibrotic adipose tissue on the buttocks, hips and limbs that develops at times of hormone, weight and shape change including puberty, pregnancy, and menopause. Lipedema tissue may be very painful and can severely impair mobility. Non-lipedema obesity, lymphedema, venous disease, and hypermobile joints are comorbidities. Lipedema tissue is difficult to reduce by diet, exercise, or bariatric surgery...
December 2021: Phlebology
keyword
keyword
166992
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.